Long Covid Patient Succesfully Treated With BC 007.

Zug, Switzerland, and Berlin, Germany, July 2021

BC 007 was successfully used for the treatment of a Long Covid Patient at Erlangen University. The 59y male patient suffered from fatigue and other typical long covid symptoms. He was positive for different GPCR-autoantibodies. After a single treatment, the symptoms improved dramatically and the microcirculation, as measured in retinal angiography, also improved significantly.

Please use a modern web browser